223 related articles for article (PubMed ID: 29319615)
1. Clinical and Pathological Features of Plasma Cell-Rich Acute Rejection After Kidney Transplantation.
Hasegawa J; Honda K; Omoto K; Wakai S; Shirakawa H; Okumi M; Ishida H; Fuchinoue S; Hattori M; Tanabe K
Transplantation; 2018 May; 102(5):853-859. PubMed ID: 29319615
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological features and outcomes of kidney allografts in plasma cell-rich acute rejection: A case series.
Hamada AM; Yamamoto I; Kawabe M; Katsumata H; Yamakawa T; Katsuma A; Nakada Y; Kobayashi A; Koike Y; Miki J; Yamada H; Kimura T; Tanno Y; Ohkido I; Tsuboi N; Yamamoto H; Yokoo T
Nephrology (Carlton); 2018 Jul; 23 Suppl 2():22-26. PubMed ID: 29968414
[TBL] [Abstract][Full Text] [Related]
3. Concurrent acute cellular rejection is an independent risk factor for renal allograft failure in patients with C4d-positive antibody-mediated rejection.
Matignon M; Muthukumar T; Seshan SV; Suthanthiran M; Hartono C
Transplantation; 2012 Sep; 94(6):603-11. PubMed ID: 22932115
[TBL] [Abstract][Full Text] [Related]
4. Plasma cell-rich acute renal allograft rejection.
Charney DA; Nadasdy T; Lo AW; Racusen LC
Transplantation; 1999 Sep; 68(6):791-7. PubMed ID: 10515379
[TBL] [Abstract][Full Text] [Related]
5. Acute Antibody-Mediated Rejection in Kidney Transplant Based on the 2013 Banff Criteria: Single-Center Experience in Uruguay.
Nin M; Coitiño R; Kurdian M; Orihuela L; Astesiano R; Garau M; López D; Rievas G; Rodriguez I; González-Martínez F; Noboa O
Transplant Proc; 2016 Mar; 48(2):612-5. PubMed ID: 27110014
[TBL] [Abstract][Full Text] [Related]
6. Plasma cell-rich acute rejections in living-related kidney transplantation: a clinicopathological study of 50 cases.
Abbas K; Mubarak M; Zafar MN; Aziz T; Abbas H; Muzaffar R; Rizvi SA
Clin Transplant; 2015 Sep; 29(9):835-41. PubMed ID: 26172154
[TBL] [Abstract][Full Text] [Related]
7. Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation.
Tsapepas DS; Vasilescu R; Tanriover B; Coppleson Y; Rekhtman Y; Hardy MA; Dube G; Crew RJ; Ratner LE; Cohen DJ; Mohan S
Transplantation; 2014 Mar; 97(6):642-7. PubMed ID: 24637863
[TBL] [Abstract][Full Text] [Related]
8. Plasma cell-rich related acute rejection in kidney transplant: A case report and review of the literature.
Tsai YY; Lim LM; Kuo HT; Tsai YC
Medicine (Baltimore); 2022 Sep; 101(36):e30493. PubMed ID: 36086682
[TBL] [Abstract][Full Text] [Related]
9. Subclinical antibody-mediated rejection due to anti-human-leukocyte-antigen-DR53 antibody accompanied by plasma cell-rich acute rejection in a patient with cadaveric kidney transplantation.
Katsuma A; Yamamoto I; Komatsuzaki Y; Niikura T; Kawabe M; Okabayashi Y; Yamakawa T; Katsumata H; Nakada Y; Kobayashi A; Tanno Y; Miki J; Yamada H; Ohkido I; Tsuboi N; Yamamoto H; Yokoo T
Nephrology (Carlton); 2016 Jul; 21 Suppl 1():31-4. PubMed ID: 26971538
[TBL] [Abstract][Full Text] [Related]
10. Plasma Cell-Rich Acute Rejection in Renal Transplantation: A Case Report.
Plaza Lara E; Hernández García E; Ruiz Fuentes MDC; Caba Molina M; De Gracia Guindo MDC; Osuna Ortega A
Transplant Proc; 2020 Mar; 52(2):512-514. PubMed ID: 32059940
[TBL] [Abstract][Full Text] [Related]
11. Long-term kidney allograft survival in patients with transplant glomerulitis.
Nabokow A; Dobronravov VA; Khrabrova M; Gröne HJ; Gröne E; Hallensleben M; Kieneke D; Weithofer P; Smirnov AV; Kliem V
Transplantation; 2015 Feb; 99(2):331-9. PubMed ID: 25594551
[TBL] [Abstract][Full Text] [Related]
12. A Banff Component Scoring-based Histologic Assessment of Bortezomib-based Antibody-mediated Rejection Therapy.
Sadaka B; Ejaz NS; Shields AR; Cardi MA; Wadih G; Witte D; Abu Jawdeh BG; Alloway RR; Woodle ES
Transplantation; 2015 Aug; 99(8):1691-9. PubMed ID: 25803498
[TBL] [Abstract][Full Text] [Related]
13. Expression patterns of B cells in acute kidney transplant rejection.
Carpio VN; Noronha Ide L; Martins HL; Jobim LF; Gil BC; Külzer AS; Loreto Mda S; Gonçalves LF; Manfro RC; Veronese FV
Exp Clin Transplant; 2014 Oct; 12(5):405-14. PubMed ID: 25299368
[TBL] [Abstract][Full Text] [Related]
14. Investigation of Serum Angiotensin II Type 1 Receptor Antibodies at the Time of Renal Allograft Rejection.
Lee H; Kim JI; Moon IS; Chung BH; Yang CW; Kim Y; Han K; Oh EJ
Ann Lab Med; 2015 May; 35(3):314-20. PubMed ID: 25932439
[TBL] [Abstract][Full Text] [Related]
15. Differences in Pathologic Features and Graft Outcomes of Rejection on Kidney Transplant.
Park WY; Paek JH; Jin K; Park SB; Choe M; Han S
Transplant Proc; 2019 Oct; 51(8):2655-2659. PubMed ID: 31345597
[TBL] [Abstract][Full Text] [Related]
16. C1q binding is not an independent risk factor for kidney allograft loss after an acute antibody-mediated rejection episode: a retrospective cohort study.
Moktefi A; Parisot J; Desvaux D; Canoui-Poitrine F; Brocheriou I; Peltier J; Audard V; Kofman T; Suberbielle C; Lang P; Rondeau E; Grimbert P; Matignon M
Transpl Int; 2017 Mar; 30(3):277-287. PubMed ID: 27992962
[TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin therapy for plasma cell-rich rejection in the renal allograft.
Adrogue HE; Soltero L; Land GA; Ramanathan V; Truong LD; Suki WN
Transplantation; 2006 Aug; 82(4):567-9. PubMed ID: 16926602
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure.
Kannabhiran D; Lee J; Schwartz JE; Friedlander R; Aull M; Muthukumar T; Campbell S; Epstein D; Seshan SV; Kapur S; Sharma VK; Suthanthiran M; Dadhania D
Transplantation; 2015 Jun; 99(6):1156-64. PubMed ID: 25629531
[TBL] [Abstract][Full Text] [Related]
19. Immunohistopathologic Characterization of Plasma Cell-Rich Acute Rejection in Living-Related Renal Transplant Recipients.
Mubarak M; Abbas K; Zafar MN; Aziz T
Exp Clin Transplant; 2017 Oct; 15(5):516-520. PubMed ID: 28467296
[TBL] [Abstract][Full Text] [Related]
20. The inferior impact of antibody-mediated rejection on the clinical outcome of kidney allografts that develop de novo thrombotic microangiopathy.
Wu K; Budde K; Schmidt D; Neumayer HH; Lehner L; Bamoulid J; Rudolph B
Clin Transplant; 2016 Feb; 30(2):105-17. PubMed ID: 26448478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
